Literature DB >> 8610701

Epidemiology of idiopathic dilated cardiomyopathy in the elderly: pooled results from two case-control studies.

S S Coughlin1, M C Tefft, J C Rice, J L Gerone, K L Baughman.   

Abstract

Although idiopathic dilated cardiomyopathy is often viewed as an affliction of young of middle-aged adults, morbidity and mortality rates from idiopathic dilated cardiomyopathy rise sharply with age and are the highest in the elderly. To learn more about the determinants of this increasingly important cause of heart failure in the elderly, the authors conducted a pooled analysis of data from two case-control studies of idiopathic dilated cardiomyopathy carried out in Baltimore, Maryland (1984-1986), and in Washington, DC (1990-1992). Identical diagnostic criteria and interviewing procedures had been used in both studies. All of the cases of idiopathic dilated cardiomyopathy had evidence of ventricular dilation and hypokinesis, with a left ventricular ejection fraction of < 40%. Cases with a history of coronary artery disease were excluded along with those with known secondary forms of cardiomyopathy, Up to two neighborhood controls of the same sex and appropriate age (+/- 5 years) were selected for each case using a random digit dialing technique. The subjects or a suitable surrogate was interviewed by telephone to obtain medical history information. The present analysis was limited to 94 cases and 152 matched controls who were at least 60 years of age. Conditional logistic regression methods were used in the analysis. Significant associations were observed with lower educational attainment and a history of hypertension (P < 0.05). The association with hypertension (relative odds = 2.2, 95% confidence interval 1.1-4.6) persisted after adjustment for race, education, and diabetes and was not accounted for by coronary angiography utilization patterns. The association with diabetes was of borderline significance (p < 0.10). The pattern of risk factors identified in this analysis may allow for the early identification of elderly persons who are at increased risk of idiopathic dilated cardiomyopathy.

Entities:  

Mesh:

Year:  1996        PMID: 8610701     DOI: 10.1093/oxfordjournals.aje.a008831

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  6 in total

1.  Loss of secreted frizzled-related protein-1 leads to deterioration of cardiac function in mice and plays a role in human cardiomyopathy.

Authors:  Piotr Sklepkiewicz; Takayuki Shiomi; Rajbir Kaur; Jie Sun; Susan Kwon; Becky Mercer; Peter Bodine; Ralph Theo Schermuly; Isaac George; P Christian Schulze; Jeanine M D'Armiento
Journal:  Circ Heart Fail       Date:  2015-02-10       Impact factor: 8.790

2.  Development of dilated cardiomyopathy in Bmal1-deficient mice.

Authors:  Mellani Lefta; Kenneth S Campbell; Han-Zhong Feng; Jian-Ping Jin; Karyn A Esser
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-15       Impact factor: 4.733

3.  N-terminal pro-B-type natriuretic peptide and long-term mortality in non-ischaemic cardiomyopathy.

Authors:  Florian Krackhardt; Hans-Dirk Düngen; Tobias Daniel Trippel; Simone Inkrot; Verena Tscholl; Peter Schlattmann; Kathrin Kehrt; Wilhelm Haverkamp
Journal:  Wien Klin Wochenschr       Date:  2011-11-23       Impact factor: 1.704

Review 4.  [Classification, genetic predisposition and risk factors for the development of cardiomyopathies].

Authors:  S Pankuweit; A Richter; V Ruppert; R Funck; B Maisch
Journal:  Internist (Berl)       Date:  2008-04       Impact factor: 0.743

5.  [Familial predisposition and microbial etiology in dilated cardiomyopathy].

Authors:  Sabine Pankuweit; Anette Richter; Volker Ruppert; Bernhard Maisch
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

6.  Incidence of idiopathic cardiomyopathy in patients with type 2 diabetes in Taiwan: age, sex, and urbanization status-stratified analysis.

Authors:  Hua-Fen Chen; Ya-Hui Chang; Hsien-Jung Lo; Muhammad Atoillah Isfandiari; Santi Martini; Wen-Hsuan Hou; Chung-Yi Li
Journal:  Cardiovasc Diabetol       Date:  2020-10-14       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.